List of the proteins that increased or decreased significantly with the progression of liver fibrosis. by Kumiko Shirai (13014884)

Subjects:

(A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

Subjects:

Encapsulation efficiency significantly decreases with increasing starting bacterial concentration. by Kelly C. Freudenberger Catanzaro (6701789)

Surface displacements after shot peening in the finite element model for different projectile diameters: (a) 0.4 mm, (b) 0.6 mm, (c) 0.8 mm, (d) 1.0 mm, and (e) surface roughness P... by Huashen Guan (20454677)

Subjects:

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

Spleen PAX5 significantly decreased in APRIL/BLyS blockade treated mice. by Natalie M. Bath (6316517)

Spectral power distributions for UV-A and UV-C light sources used in the experiments. by Rachael Guenter (15147776)

Subjects:

Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization. by Kun Cui (2070772)

Consort Flow diagram. by Khashayar Afshari (11993660)

Subjects:

BMI and body fat percentage association. by Khashayar Afshari (11993660)

Subjects:

Bone density changes. by Khashayar Afshari (11993660)

Subjects:

Lean and fat mass changes. by Khashayar Afshari (11993660)

Subjects:

Baseline features of enrolled individuals. by Khashayar Afshari (11993660)

Subjects:

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

As compared to HD, RRMS and T1D patients show significantly greater preponderance of rs2281808 CT/TT carriers. by Sushmita Sinha (348580)

DNA damage after UV-A/UV-C light exposure assessed by a comet assay. by Rachael Guenter (15147776)

Subjects:

Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

Subjects:

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Subjects:

Plasma cells, but not memory B cells, were significantly decreased with APRIL/BLyS blockade. by Natalie M. Bath (6316517)